(Allergan plc)

	AGN latest price $275.4288 (1.32%) ($269.5558 - $277.1178) on Fri. Feb. 13, 2015.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.86% (three month average)
RSI	47
Latest Price	$275.4288(1.32%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.6% a day on average for past five trading days.
Weekly Trend	AGN advances 0.8% a week on average for past two weeks.
Market Behavior	Value stock rally for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   XLV(55%)    IBB(54%)    XBI(47%)    SPY(43%)    QQQ(42%)
Factors Impacting AGN price	AGN will decline at least -0.93% in a week (0% probabilities).   VIXM(-31%)    TLT(-18%)    SHY(-7%)    UUP(-6%)    IGOV(-4%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.93% (StdDev 1.86%)
Hourly BBV	0 ()
Intraday Trend	1.6%

5 Day Moving Average	$269.47(2.21%)
10 Day Moving Average	$265.72(3.65%)
20 Day Moving Average	$265.46(3.76%)
To recent high	0%
To recent low	18.1%
Market Cap	$90.809b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed